In her current role as associate dean at the Williams School, Alexander manages the schools Association to Advance Collegiate Schools of Business (AACSB) reaccreditation, oversees enrollment activities, and manages strategic planning initiatives that build connections between the business curriculum and the liberal arts. In addition to serving as associate dean, Alexander holds the appointment of the Ehrick Kilner Haight, Sr. Term Professor of Accounting. Alexanders research focuses on tax policy related to personal savings and corporate taxation and has been published in top journals such as the Journal of the American Taxation Association, Behavioral Research in Accounting and the Journal of Law and Politics. her comment is hereShe has written for The New York Times and her research has been cited in such media outlets as The Wall Street Journal, The Atlantic, Business Week and CNBC. Her work has led to reform in the college savings industry, and has been used by policy makers and regulators at the SEC, the Municipal Securities Rulemaking Board, Financial Industry Regulatory Authority and the White House. She has also consulted or provided executive education to a number of firms and investment professionals around the country and is currently the vice president for the American Taxation Association. Raquels confidence, collaborative spirit and leadership qualities are immediately evident, said Bucknell Provost Barbara Altmann, who chaired the 13-person search committee. Her zeal for undergraduate education, coupled with her impressive set of experiences and accomplishments, make her uniquely qualified to lead our new College of Management. Alexander will join Bucknell in July 2017, the same month the University officially establishes its College of Management. The third college marks a historic milestone in the evolution of the Universitys management and business education, which dates back more than a century.
For the original version including any supplementary images or video, visit http://www.sungazette.com/news/education/2016/12/bucknell-university-announces-inaugural-dean-of-management/
and $1.5 billion globally according to Wall Street estimates. About AzurRx BioPharma, Inc.: AzurRx BioPharma, Inc. ( AZRX ) is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. MS1819 recombinant lipase for exocrine pancreatic insufficiency is the Company’s lead development program, and additional early stage research is being conducted for the prevention of hospital-acquired infections. The Company is headquartered in Brooklyn, NY, with scientific operations based in Langlade, France.Additional information on the company can be found at www.azurrx.com . About Laboratoires Mayoly Spindler, SAS Mayoly Spindler is a French, independent, family-owned pharmaceutical company, active in research, development, manufacturing, registration and marketing of pharmaceuticals and dermo-cosmetics in more than 70 countries. visit our websiteThe company aims to become a global reference in gastroenterology and dermocosmetics. Mayoly Spindler is headquartered in the Paris area of France, and employs 750 people worldwide. Mayoly Spindler website address: www.mayoly-spindler.com About Endocrine Pancreatic Insufficiency: ExocrinePancreatic Insufficiency(EPI) is a condition characterized by deficiency of the exocrinepancreaticenzymes, resulting in the inability to digest food properly, or maldigestion. The deficiency in this enzyme can be responsible for greasy diarrhea, fecal urge and weight loss.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/azurrx-biopharma-announces-first-three-130000577.html